Annual Non Current Assets
$444.33 M
+$95.25 M+27.29%
September 30, 2024
Summary
- As of February 7, 2025, ARWR annual long term assets is $444.33 million, with the most recent change of +$95.25 million (+27.29%) on September 30, 2024.
- During the last 3 years, ARWR annual non current assets has risen by +$118.78 million (+36.49%).
- ARWR annual non current assets is now at all-time high.
Performance
ARWR Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$444.33 M
+$10.63 M+2.45%
September 30, 2024
Summary
- As of February 7, 2025, ARWR quarterly long term assets is $444.33 million, with the most recent change of +$10.63 million (+2.45%) on September 30, 2024.
- Over the past year, ARWR quarterly non current assets has increased by +$30.83 million (+7.46%).
- ARWR quarterly non current assets is now at all-time high.
Performance
ARWR Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
ARWR Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.3% | +7.5% |
| 3 y3 years | +36.5% | +36.5% |
| 5 y5 years | +425.2% | +36.5% |
ARWR Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +55.0% | at high | +55.4% |
| 5 y | 5-year | at high | +425.2% | at high | +455.5% |
| alltime | all time | at high | >+9999.0% | at high | -100.0% |
Arrowhead Pharmaceuticals Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $695.47 M(+67.0%) | $444.33 M(+2.5%) |
| Jun 2024 | - | $433.70 M(+4.9%) |
| Mar 2024 | - | $413.50 M(+6.5%) |
| Dec 2023 | - | $388.39 M(+11.3%) |
| Sep 2023 | $416.47 M(+2.8%) | $349.08 M(+7.2%) |
| Jun 2023 | - | $325.69 M(+2.9%) |
| Mar 2023 | - | $316.50 M(+0.0%) |
| Dec 2022 | - | $316.49 M(+10.4%) |
| Sep 2022 | $405.30 M(+5.4%) | $286.64 M(-10.3%) |
| Jun 2022 | - | $319.39 M(+11.7%) |
| Mar 2022 | - | $285.94 M(-4.8%) |
| Dec 2021 | - | $300.26 M(-7.8%) |
| Sep 2021 | $384.60 M(+19.3%) | $325.55 M(+55.8%) |
| Jun 2021 | - | $208.97 M(+22.9%) |
| Mar 2021 | - | $170.04 M(-3.1%) |
| Dec 2020 | - | $175.53 M(-12.3%) |
| Sep 2020 | $322.37 M(+21.5%) | $200.13 M(-16.8%) |
| Jun 2020 | - | $240.50 M(-2.5%) |
| Mar 2020 | - | $246.60 M(+208.3%) |
| Dec 2019 | - | $79.99 M(-5.5%) |
| Sep 2019 | $265.25 M(+236.7%) | $84.60 M(-8.3%) |
| Jun 2019 | - | $92.29 M(-6.7%) |
| Mar 2019 | - | $98.97 M(+7.6%) |
| Dec 2018 | - | $92.00 M(+180.1%) |
| Sep 2018 | $78.77 M(+16.0%) | $32.84 M(-35.6%) |
| Jun 2018 | - | $51.03 M(+48.6%) |
| Mar 2018 | - | $34.34 M(-2.2%) |
| Dec 2017 | - | $35.11 M(-2.8%) |
| Sep 2017 | $67.90 M(-25.0%) | $36.12 M(-2.9%) |
| Jun 2017 | - | $37.18 M(-0.0%) |
| Mar 2017 | - | $37.18 M(-2.2%) |
| Dec 2016 | - | $38.03 M(+0.9%) |
| Sep 2016 | $90.50 M(-12.0%) | $37.67 M(+4.8%) |
| Jun 2016 | - | $35.93 M(+26.2%) |
| Mar 2016 | - | $28.46 M(-2.2%) |
| Dec 2015 | - | $29.10 M(-1.0%) |
| Sep 2015 | $102.87 M(-33.5%) | $29.40 M(-3.6%) |
| Jun 2015 | - | $30.50 M(-27.8%) |
| Mar 2015 | - | $42.23 M(+40.9%) |
| Dec 2014 | - | $29.97 M(+7.0%) |
| Sep 2014 | $154.80 M(+436.7%) | $28.02 M(-15.6%) |
| Jun 2014 | - | $33.20 M(-18.5%) |
| Mar 2014 | - | $40.72 M(+150.1%) |
| Dec 2013 | - | $16.28 M(+91.9%) |
| Sep 2013 | $28.84 M(+339.2%) | $8.49 M(+19.9%) |
| Jun 2013 | - | $7.08 M(-18.5%) |
| Mar 2013 | - | $8.68 M(-5.3%) |
| Dec 2012 | - | $9.17 M(-8.0%) |
| Sep 2012 | $6.57 M | $9.96 M(-5.9%) |
| Jun 2012 | - | $10.59 M(-6.0%) |
| Mar 2012 | - | $11.26 M(-18.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | - | $13.89 M(+130.4%) |
| Sep 2011 | $9.86 M(+21.3%) | $6.03 M(-3.4%) |
| Jun 2011 | - | $6.24 M(-6.2%) |
| Mar 2011 | - | $6.66 M(+60.4%) |
| Dec 2010 | - | $4.15 M(-1.7%) |
| Sep 2010 | $8.13 M(+227.4%) | $4.22 M(-5.5%) |
| Jun 2010 | - | $4.47 M(-6.2%) |
| Mar 2010 | - | $4.77 M(-4.3%) |
| Dec 2009 | - | $4.98 M(-4.6%) |
| Sep 2009 | $2.48 M(-76.5%) | $5.22 M(-4.1%) |
| Jun 2009 | - | $5.44 M(-9.1%) |
| Mar 2009 | - | $5.99 M(-6.0%) |
| Dec 2008 | - | $6.37 M(-4.9%) |
| Sep 2008 | $10.56 M(-58.3%) | $6.69 M(+46.0%) |
| Jun 2008 | - | $4.58 M(+7.2%) |
| Mar 2008 | - | $4.28 M(-4.0%) |
| Dec 2007 | - | $4.46 M(-2.0%) |
| Sep 2007 | $25.31 M(-12.1%) | $4.55 M(-1.4%) |
| Jun 2007 | - | $4.61 M(+4.5%) |
| Mar 2007 | - | $4.41 M(-21.1%) |
| Dec 2006 | - | $5.59 M(-2.8%) |
| Sep 2006 | $28.78 M(+26.1%) | $5.75 M(-37.8%) |
| Jun 2006 | - | $9.24 M(+3.0%) |
| Mar 2006 | - | $8.97 M(+41.0%) |
| Dec 2005 | - | $6.36 M(+2.2%) |
| Sep 2005 | $22.81 M(+140.2%) | $6.23 M(+23.5%) |
| Jun 2005 | - | $5.04 M(+3.8%) |
| Mar 2005 | - | $4.86 M(+79.3%) |
| Dec 2004 | - | $2.71 M(+12.0%) |
| Sep 2004 | $9.50 M(+527.3%) | $2.42 M(+99.6%) |
| Jun 2004 | - | $1.21 M(>+9900.0%) |
| Mar 2004 | - | $9600.00(+433.3%) |
| Dec 2003 | - | $1800.00(-10.0%) |
| Sep 2003 | $1.51 M(+4616.2%) | $2000.00(-92.4%) |
| Jun 2003 | - | $26.30 K(-6.1%) |
| Mar 2003 | - | $28.00 K(-5.7%) |
| Dec 2002 | - | $29.70 K(-5.4%) |
| Sep 2002 | $32.10 K(-30.1%) | $31.40 K(-11.3%) |
| Jun 2002 | - | $35.40 K(+1670.0%) |
| Mar 2002 | - | $2000.00(+400.0%) |
| Dec 2001 | - | $400.00(0.0%) |
| Sep 2001 | $45.90 K(+185.1%) | $400.00(>+9900.0%) |
| Jun 2001 | - | $0.00(0.0%) |
| Mar 2001 | - | $0.00(-100.0%) |
| Dec 2000 | - | $46.70 K(-4.9%) |
| Sep 2000 | $16.10 K(-38.8%) | $49.10 K(-2.8%) |
| Jun 2000 | - | $50.50 K(-4.0%) |
| Mar 2000 | - | $52.60 K(-3.7%) |
| Dec 1999 | - | $54.60 K |
| Sep 1999 | $26.30 K(+19.5%) | - |
| Sep 1998 | $22.00 K(-35.5%) | - |
| Sep 1997 | $34.10 K | - |
FAQ
- What is Arrowhead Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual non current assets year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly non current assets year-on-year change?
What is Arrowhead Pharmaceuticals annual long term assets?
The current annual non current assets of ARWR is $444.33 M
What is the all time high annual non current assets for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual long term assets is $444.33 M
What is Arrowhead Pharmaceuticals annual non current assets year-on-year change?
Over the past year, ARWR annual long term assets has changed by +$95.25 M (+27.29%)
What is Arrowhead Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of ARWR is $444.33 M
What is the all time high quarterly non current assets for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly long term assets is $444.33 M
What is Arrowhead Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, ARWR quarterly long term assets has changed by +$30.83 M (+7.46%)